This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: St Phi Therapeutics Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Wenting Zhong: Innovator in Immune Response Engineering
Introduction
Wenting Zhong is a notable inventor based in Wuping, China. He has made significant contributions to the field of immunology through his innovative work on chimeric endocytic receptors. His research focuses on enhancing immune responses, which has important implications for treating various diseases.
Latest Patents
Wenting Zhong holds a patent for "Chimeric endocytic receptors and method of use thereof." This invention discloses chimeric endocytic receptor (CER)-based constructs designed to activate and regulate immune responses. The constructs are based on the structure of FcγRI/γ chain and incorporate high-affinity binding domains from receptors or antibodies that can uptake specific antigens. This process allows for the presentation of antigens to T cells or B cells, initiating an antigen-specific immune response. The engineered CER-expressing monocytes (CER-M) or T cells (CER-T) can recognize and uptake target antigens, activating subsequent immune responses. This innovative design has potential applications in treating tumors, viral diseases, and autoimmune diseases.
Career Highlights
Wenting Zhong is currently associated with St Phi Therapeutics Co., Ltd., where he continues to advance his research in immunotherapy. His work has positioned him as a key figure in the development of novel therapeutic strategies aimed at enhancing immune system functionality.
Collaborations
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile